Developer docs
API playgroundTry for free, no card

Search company profiles

Carnot Chimie Balard CIRIMAT

Full company profile

uuid00437g8

Namestring
Carnot Chimie Balard CIRIMAT
Legal namestring
Chimie Balard Cirimat Carnot Institute
Company typeenum
Private
Founded yearint
2006
Descriptiontext

The Institut Carnot Chimie Balard CIRIMAT (CBC Carnot Institute) is a French public research partnership institute formed in 2016 from the merger of Institut Carnot Cirimat and Institut Carnot Chimie Balard, granted the Carnot label by the Ministry of Higher Education, Research and Innovation since 2006. It operates under the direct supervision of five French research and education institutions — CNRS, École Nationale Supérieure de Chimie de Montpellier (ENSCM), Institut National Polytechnique de Toulouse, Université de Toulouse, and Université de Montpellier — and unites more than 800 research personnel across four joint research units (ICGM, IBMM, IEM, CIRIMAT) in Montpellier and Toulouse. Its core activity is contract-based partnership research with industrial companies across five thematic areas: Energy (fuel cells, batteries, hydrogen, photovoltaics), Green Chemistry and Processes (bio-based polymers, alternative solvents, mechanochemistry, eco-extraction), Health and Cosmetics (bioactive molecules, drug delivery, medical devices, cosmetic formulations), Materials for Transport (aeronautics, space, automotive, rail), and High Performance Materials (alloys, oxides, thin films, spark plasma sintering, additive manufacturing).

The institute monetizes through a structured five-step partnership model: companies identify innovation needs, institute experts propose technical solutions, contracts are formalized, research is executed in laboratories and on technology platforms, and innovations are transferred back to the partner. It operates six shared technology platforms — ChemLab industrial pilot plant, MultiFab additive manufacturing, Balard Analysis and Characterization Platform (PAC), National Spark Plasma Sintering Platform (PNF2-CNRS), SynBio3 peptide/polymer synthesis, and scale-up tools — which generate fee-for-service revenue alongside R&D contracts. Pricing is custom by project; no standardized tiers are published. Complementary revenue streams include training programs delivered with CNRS Formation Entreprises and intellectual-property licensing for developed technologies.

For the most recent reporting period, the institute executed 486 industrial contracts, filed 41 patents, recorded €31.8 million in partnership research funding, and engaged partners across 18 dedicated events. Named industrial customers span large enterprise (Thales Alenia Space, Inventec, Aeterna Zentaris, Shire/Takeda) and startup/spin-off partners (Athéor, Norimat, Womed, NanoMedSyn, Sÿnia, Biomanity, Bulane). The institute has produced commercially validated outputs including FDA-authorized Macrilen™ (via Aeterna Zentaris) and EMA orphan-drug designation for NanoMedSyn's Pompe-disease program, and has won multiple innovation prizes (Grand Prix iLab 2018, Carnot 2023 Prize, Grand Prix Siemens 2010, Afaq quality certification 2025).

Short descriptiontext

The Institut Carnot Chimie Balard CIRIMAT is a French public research partnership institute, formed in 2016, that delivers contract R&D in chemistry, materials, and processes to industrial clients across energy, green chemistry, health, cosmetics, transport, and high-performance materials.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMontpellier, France
HQ citystring
Montpellier
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
partnership research services, chemistry materials research, green chemistry solutions, technology platform access, industrial R&D collaboration
Industry3 codes
1Science, Technology & Innovation Administration (National R&D Policy)
CodeBPAIAAAKPrimaryYes
2Additive Manufacturing Research & Innovation Labs
CodeIMAAAJAAPrimaryNo
3Industry-Specific Technical & Certification Prep (e.g., Construction, Manufacturing, Energy)
CodeEDAGANANPrimaryNo
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Industrial Contract R&D and Technology Platforms (Chemistry, Materials and Processes)
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Partnership Research Contracts
TypeProfessional Services
Description

Contract-based collaborative research with industrial partners across 5 thematic areas. Companies engage the institute to develop new products, conquer new markets, or improve existing products through structured R&D partnerships.

carnot-chimie-balard-cirimat.fr
2Technology Platform Services
TypeProfessional Services
Description

Access to unique technology platforms for synthesis, shaping, and characterization of molecules and materials. Includes services through ChemLab ENSCM, MultiFab additive manufacturing, Balard Analysis and Characterization Platform (PAC), National Spark Plasma Sintering Platform (PNF2), SynBio3, and scale-up tools.

carnot-chimie-balard-cirimat.fr
3Training Programs
TypeProfessional Services
Description

Competency transfer and R&D training programs for companies delivered in partnership with CNRS Formation Entreprises. Topics include HPLC purification, mechanochemistry, sol-gel coatings, oligonucleotide synthesis, electrochemical characterization.

carnot-chimie-balard-cirimat.fr
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Custom Research Partnership Projects
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing determined through consultation based on project scope, duration, and specific R&D requirements

carnot-chimie-balard-cirimat.fr
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The institute provides contract-based partnership research in Chemistry, Materials and Processes across five thematic areas (Energy, Green Chemistry and Processes, Health and Cosmetics, Materials for Transport, High Performance Materials), backed by six shared technology platforms for synthesis, characterization, additive manufacturing, spark plasma sintering, and scale-up. It also licenses proprietary technologies such as Glass'in® and Ecorel™ Oxal AG, supports spin-off creation, and delivers competency-transfer training programs for industrial partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • €31.8 million in partnership research funding
+8 more records
Product overview1 text field

Carnot Chimie Balard CIRIMAT is a public research institute offering partnership research services in chemistry, materials, and processes. The institute provides five core research service areas: Energy, Green Chemistry and Processes, Health and Cosmetics, Materials for Transport, and High Performance Materials. These research services are supported by six technology platforms (ChemLab, MultiFab, Balard Analysis and Characterization Platform, National Spark Plasma Sintering Platform, SynBio3, and Scale-up Tools) that provide synthesis, characterization, and shaping capabilities for molecules and materials. The institute also facilitates technology transfer through licensing arrangements for developed innovations such as Glass'in® glass marking technology, and supports commercialization of developed products like Ecorel™ Oxal AG solder paste and biobased materials.

Product and service11 records
1Research Partnership Services in Energy
CategoryPartnership Research Services
Description

Contract R&D for industrial partners in energy: fuel cells, Li+/Na+ batteries, supercapacitors, hydrogen production, photovoltaic materials, thermoelectricity, piezoelectricity and new fuels.

2Research Partnership Services in Green Chemistry and Processes
CategoryPartnership Research Services
Description

Contract R&D for alternative solvents, solvent-free synthesis, mechanochemistry, bio-based molecules, biomass conversion, wastewater treatment and eco-extraction.

3Research Partnership Services in Health and Cosmetics
CategoryPartnership Research Services
Description

Contract R&D for synthesis of bioactive molecules, hybrid materials, drug transport and delivery systems, vectors and probes for living organisms, innovative medical devices and cosmetic formulations.

4Research Partnership Services in Materials for Transport
CategoryPartnership Research Services
Description

Contract R&D for aeronautics, space, automotive and railway: structural materials for high temperatures, polymer aging, hybrid composites, brazing materials for power electronics.

5Research Partnership Services in High Performance Materials
CategoryPartnership Research Services
Description

Contract R&D on synthesis and shaping of alloys, oxides, thin films, protective coatings, nano-composites, carbon-based materials (graphene, nanotubes), spark plasma sintering, additive manufacturing.

6ChemLab ENSCM Industrial Pilot Plant
CategoryTechnology Platform
Description

Industrial pilot plant at the National School of Chemistry of Montpellier enabling industrial partners to develop processes or carry out synthesis and extraction at various scales.

7MultiFab Additive Manufacturing Platform
CategoryTechnology Platform
Description

Platform dedicated to development and transfer of 3D printing technologies for industrial and academic partners, including multi-material and multi-scale manufacturing capabilities.

8Balard Analysis and Characterization Platform (PAC)
CategoryTechnology Platform
Description

High-tech equipment hub for physico-chemical analysis and characterization, from molecules to materials, open to industrial partners.

9National Spark Plasma Sintering Platform (PNF2-CNRS)
CategoryTechnology Platform
Description

Platform at CIRIMAT in Toulouse for shaping materials using SPS (Spark Plasma Sintering) technology, open to public and private laboratories.

10SynBio3 Peptide and Polymer Synthesis Platform
CategoryTechnology Platform
Description

Interface platform between chemistry and biology offering peptide and polymer synthesis services for academics and industrialists in medicine, biology, chemistry and pharmacology.

11Corporate Training Programs (CNRS Formation Entreprises)
CategoryTraining Services
Description

Competency transfer and R&D training programs delivered with CNRS Formation Entreprises covering HPLC purification, mechanochemistry, sol-gel coatings, oligonucleotide synthesis, electrochemical characterization, peptide synthesis and nanoparticle systems.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership23 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Global biotech company entered collaboration agreement in March 2018 for application of NanoMedSyn AMFA technology in Pompe disease treatment. Shire/Takeda (Cambridge, MA) supporting development of lysosomal storage disorder therapies.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2016-01-01
Description

Primary research partner providing institutional support and framework. The institute depends directly on CNRS as one of its 5 educational institution supervisors. CNRS researchers including Olivier Dautel, Claude Estournès, Emmanuel Flahaut, Laure Monconduit lead key research programs.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2011-01-01
Description

Space technology company partnered with CIRIMAT to develop Ecorel™ Oxal AG high thermal conductivity solder for embedded electronics in satellites. Contributed to patent deposit in 2011.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2006-01-01
Description

Host institution for ICGM and IBMM research units. Provides ChemLab industrial pilot plant facility for company partnerships. Located at 240 av. du Pr. E. Jeanbrau, Montpellier.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2006-01-01
Description

Host institution for CIRIMAT research unit in Toulouse. Supports the National Spark Plasma Sintering Platform (PNF2-CNRS).

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2006-01-01
Description

University partner hosting CIRIMAT laboratory at 118 route de Narbonne, Toulouse. University Toulouse III-Paul Sabatier researchers contributed to Mobilint and Ecorel patents.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2006-01-01
Description

University partner hosting ICGM and IBMM research units. Supports SATT AxLR technology transfer. Home to IBMM's Artificial Biopolymers Department where Womed is headquartered.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Company commercializing Ecorel™ Oxal AG high thermal conductivity solder pastes developed from CIRIMAT-Thales research. Licensed the technology for aerospace, power electronics, and optoelectronics applications. Presented at SMT trade show 2018.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Startup founded 2009 by Jean-Denis Borras and Dr. Olivier Dautel exploiting Glass'in® technology from ICGM. Multiple research collaboration contracts since 2008, with 4 contracts including CNRS-funded R&D engineer placement.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

SME with 18 employees specializing in high-end digital printing, European leader in doming since 2005. CIFRE thesis collaboration with ICGM resulted in bio-sourced polyurethane resin and 2 international patents. Awarded Carnot 2023 prize.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Biotech PME founded 2012 developing targeted therapies based on mannose 6-phosphate receptor pathway. Spin-off from IRCM, IBMM, ICGM. Received EMA orphan drug designation. Collaborates with Shire/Takeda on Pompe disease treatment.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Medtech startup founded February 2018 developing Womed Leaf biodegradable intrauterine barrier. Spin-off from IBMM Artificial Biopolymers and CHU Nîmes. Won Grand Prix iLab 2018. Founded by Gonzague Issenmann, Xavier Garric, Stéphanie Huberlant.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Spin-off from CIRIMAT founded 2016 by Romain Epherre, Yannick Beynet, and Claude Estournès. Licensed Mobilint patent from SATT TTT for flash sintering applications in aeronautics.

14Biomanity
Strategic tierMajorTypeStrategic or Co-development Partner
Description

French biotech startup developing 100% biodegradable, bio-sourced superabsorbent polymer from chitosan platform molecule. Pr. Ghislain David joined as CTO after research collaboration. Applications in cosmetics, hygiene, agriculture.

carnot-chimie-balard-cirimat.fr
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research institute collaborating on NanoMedSyn targeted therapy development as part of translational approach involving IRCM, IBMM, and ICGM.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Industrial participant in CO2 capture and valorization day (March 2025) with presentation by Thomas De Charette on decarbonation strategies.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Industrial partner participating in CO2 capture and valorization industry day showcasing institute capabilities in carbon utilization research.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Academic collaboration with IBMM's Green Chemistry team on continuous flow metathesis research published in Green Chemistry journal (2017).

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Technology Transfer Acceleration Company supporting invention disclosure, patent filing, and startup creation for Womed and other institute spin-offs.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Technology transfer partner signing Mobilint license agreement with Norimat in November 2017 for CIRIMAT patent commercialization.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partner co-leading MultiFab platform for multi-material additive manufacturing with CIRIMAT. Funded by FEDER and Occitanie Region.

Strategic tierSupportingTypeOthers
Description

Patient organization supporting NanoMedSyn research on lysosomal storage disorders, including VML-Swiss collaboration.

23Association Française contre les Myopathies (AFM-Téléthon)
Strategic tierSupportingTypeOthers
Description

French muscular dystrophy association supporting NanoMedSyn research on lysosomal storage disorders through patient advocacy and funding.

carnot-chimie-balard-cirimat.fr
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Norway's largest contract research organization with materials, chemistry, and applied process engineering programs for Nordic and European industries. Compares directly to CBC's mix of industry-partnership research, technology platform access, and spin-off generation.

TypeBroad incumbent
Description

UK's national measurement institute with extensive capabilities in materials characterization, analytical chemistry, and standards — directly analogous to CBC's Balard Analysis and Characterization Platform (PAC). Serves industrial clients with metrology and contract research services.

TypeDirect peer
Description

Spain's largest public research institution, operating across chemistry, materials, and life sciences with industrial partnership programs. Comparable in scale, thematic breadth, and the public-institute contract-research model applied to European industry.

TypeDirect peer
Description

Dutch public applied-research organization with industry-partnership programs in energy, materials, and circular chemistry. Like CBC, TNO operates national technology platforms and licenses spin-outs, making it a directly comparable European public R&D partnership model.

TypeDirect peer
Description

France's largest public research organization with deep capabilities in energy, materials, and chemistry. Operates multiple technology platforms and partnership research programs with industry — a close structural analog to Carnot Chimie Balard CIRIMAT's Carnot institute model, and a frequent co-applicant on French national R&D programs.

TypeDirect peer
Description

UK Catapult center focused on advanced manufacturing and additive manufacturing R&D with industrial partners. Shares the model of operating dedicated technology platforms (analogous to CBC's MultiFab and PNF2 platforms) funded by a mix of public grants and industry contracts.

TypeDirect peer
Description

Germany's applied research network with 76 institutes conducting contract research for industry across materials, chemistry, surface engineering, and manufacturing. The Fraunhofer model is the most-cited international comparator for the French Carnot institute structure, including revenue mix (public base + industry contracts) and IP/spin-off generation.

TypeBroad incumbent
Description

CEA's micro/nanotechnology R&D laboratory serving semiconductor and advanced materials industries. While its thematic focus (microelectronics, MEMS) differs from CBC's chemistry/materials breadth, its public-private partnership model and platform-licensing approach are highly comparable.

9Institut de Recherche Paul Pascal (CNRS UMR 5031)
TypeDirect peer
Description

CNRS-hosted chemistry and materials research unit in Bordeaux with strong industry-partnership heritage in polymers, soft matter, and nanochemistry. Directly comparable as a French public chemistry/materials unit conducting contract research with industrial partners and producing spin-offs.

TypeDirect peer
Description

Another French Carnot institute focused on materials, microelectronics, and industrial processes. Shares the Carnot label, public funding model, and industry-partnership structure with CBC, with significant overlap in materials engineering and additive manufacturing R&D.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment10 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Carnot Chimie Balard CIRIMAT

Industrial Contract R&D and Technology Platforms (Chemistry, Materials and Processes)carnot-chimie-balard-cirimat.fr

The Institut Carnot Chimie Balard CIRIMAT is a French public research partnership institute, formed in 2016, that delivers contract R&D in chemistry, materials, and processes to industrial clients across energy, green chemistry, health, cosmetics, transport, and high-performance materials.

What Carnot Chimie Balard CIRIMAT does

The Institut Carnot Chimie Balard CIRIMAT (CBC Carnot Institute) is a French public research partnership institute formed in 2016 from the merger of Institut Carnot Cirimat and Institut Carnot Chimie Balard, granted the Carnot label by the Ministry of Higher Education, Research and Innovation since 2006. It operates under the direct supervision of five French research and education institutions — CNRS, École Nationale Supérieure de Chimie de Montpellier (ENSCM), Institut National Polytechnique de Toulouse, Université de Toulouse, and Université de Montpellier — and unites more than 800 research personnel across four joint research units (ICGM, IBMM, IEM, CIRIMAT) in Montpellier and Toulouse. Its core activity is contract-based partnership research with industrial companies across five thematic areas: Energy (fuel cells, batteries, hydrogen, photovoltaics), Green Chemistry and Processes (bio-based polymers, alternative solvents, mechanochemistry, eco-extraction), Health and Cosmetics (bioactive molecules, drug delivery, medical devices, cosmetic formulations), Materials for Transport (aeronautics, space, automotive, rail), and High Performance Materials (alloys, oxides, thin films, spark plasma sintering, additive manufacturing).

The institute monetizes through a structured five-step partnership model: companies identify innovation needs, institute experts propose technical solutions, contracts are formalized, research is executed in laboratories and on technology platforms, and innovations are transferred back to the partner. It operates six shared technology platforms — ChemLab industrial pilot plant, MultiFab additive manufacturing, Balard Analysis and Characterization Platform (PAC), National Spark Plasma Sintering Platform (PNF2-CNRS), SynBio3 peptide/polymer synthesis, and scale-up tools — which generate fee-for-service revenue alongside R&D contracts. Pricing is custom by project; no standardized tiers are published. Complementary revenue streams include training programs delivered with CNRS Formation Entreprises and intellectual-property licensing for developed technologies.

For the most recent reporting period, the institute executed 486 industrial contracts, filed 41 patents, recorded €31.8 million in partnership research funding, and engaged partners across 18 dedicated events. Named industrial customers span large enterprise (Thales Alenia Space, Inventec, Aeterna Zentaris, Shire/Takeda) and startup/spin-off partners (Athéor, Norimat, Womed, NanoMedSyn, Sÿnia, Biomanity, Bulane). The institute has produced commercially validated outputs including FDA-authorized Macrilen™ (via Aeterna Zentaris) and EMA orphan-drug designation for NanoMedSyn's Pompe-disease program, and has won multiple innovation prizes (Grand Prix iLab 2018, Carnot 2023 Prize, Grand Prix Siemens 2010, Afaq quality certification 2025).

Carnot Chimie Balard CIRIMAT firmographics

Firmographics
Name
Carnot Chimie Balard CIRIMAT
Legal name
Chimie Balard Cirimat Carnot Institute
Website
https://carnot-chimie-balard-cirimat.fr
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
The Institut Carnot Chimie Balard CIRIMAT is a French public research partnership institute, formed in 2016, that delivers contract R&D in chemistry, materials, and processes to industrial clients across energy, green chemistry, health, cosmetics, transport, and high-performance materials.
Ownership category
akta.pro rank

Carnot Chimie Balard CIRIMAT industry classification

Industry
Product category
Industrial Contract R&D and Technology Platforms (Chemistry, Materials and Processes)
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Science, Technology & Innovation Administration (National R&D Policy) (BPAIAAAK)
akta.pro secondary industries
Additive Manufacturing Research & Innovation Labs (IMAAAJAA), Industry-Specific Technical & Certification Prep (e.g., Construction, Manufacturing, Energy) (EDAGANAN)

Keywords

  • Partnership research services
  • Chemistry materials research
  • Green chemistry solutions
  • Technology platform access
  • Industrial R&D collaboration

Where Carnot Chimie Balard CIRIMAT is headquartered

Location

Headquarters

HQ city
Montpellier
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Carnot Chimie Balard CIRIMAT business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Partnership Research Contracts: Contract-based collaborative research with industrial partners across 5 thematic areas. Companies engage the institute to develop new products, conquer new markets, or improve existing products through structured R&D partnerships.
  2. Technology Platform Services: Access to unique technology platforms for synthesis, shaping, and characterization of molecules and materials. Includes services through ChemLab ENSCM, MultiFab additive manufacturing, Balard Analysis and Characterization Platform (PAC), National Spark Plasma Sintering Platform (PNF2), SynBio3, and scale-up tools.
  3. Training Programs: Competency transfer and R&D training programs for companies delivered in partnership with CNRS Formation Entreprises. Topics include HPLC purification, mechanochemistry, sol-gel coatings, oligonucleotide synthesis, electrochemical characterization.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom Research Partnership Projects

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Carnot Chimie Balard CIRIMAT product offering

Product offering

Core offering

The institute provides contract-based partnership research in Chemistry, Materials and Processes across five thematic areas (Energy, Green Chemistry and Processes, Health and Cosmetics, Materials for Transport, High Performance Materials), backed by six shared technology platforms for synthesis, characterization, additive manufacturing, spark plasma sintering, and scale-up. It also licenses proprietary technologies such as Glass'in® and Ecorel™ Oxal AG, supports spin-off creation, and delivers competency-transfer training programs for industrial partners.

Product overview

Carnot Chimie Balard CIRIMAT is a public research institute offering partnership research services in chemistry, materials, and processes. The institute provides five core research service areas: Energy, Green Chemistry and Processes, Health and Cosmetics, Materials for Transport, and High Performance Materials. These research services are supported by six technology platforms (ChemLab, MultiFab, Balard Analysis and Characterization Platform, National Spark Plasma Sintering Platform, SynBio3, and Scale-up Tools) that provide synthesis, characterization, and shaping capabilities for molecules and materials. The institute also facilitates technology transfer through licensing arrangements for developed innovations such as Glass'in® glass marking technology, and supports commercialization of developed products like Ecorel™ Oxal AG solder paste and biobased materials.

Differentiator

Problem solved

Functional benefit

Products and services

  • Research Partnership Services in Energy Contract R&D for industrial partners in energy: fuel cells, Li+/Na+ batteries, supercapacitors, hydrogen production, photovoltaic materials, thermoelectricity, piezoelectricity and new fuels.
  • Research Partnership Services in Green Chemistry and Processes Contract R&D for alternative solvents, solvent-free synthesis, mechanochemistry, bio-based molecules, biomass conversion, wastewater treatment and eco-extraction.
  • Research Partnership Services in Health and Cosmetics Contract R&D for synthesis of bioactive molecules, hybrid materials, drug transport and delivery systems, vectors and probes for living organisms, innovative medical devices and cosmetic formulations.
  • Research Partnership Services in Materials for Transport Contract R&D for aeronautics, space, automotive and railway: structural materials for high temperatures, polymer aging, hybrid composites, brazing materials for power electronics.
  • Research Partnership Services in High Performance Materials Contract R&D on synthesis and shaping of alloys, oxides, thin films, protective coatings, nano-composites, carbon-based materials (graphene, nanotubes), spark plasma sintering, additive manufacturing.
  • ChemLab ENSCM Industrial Pilot Plant Industrial pilot plant at the National School of Chemistry of Montpellier enabling industrial partners to develop processes or carry out synthesis and extraction at various scales.
  • MultiFab Additive Manufacturing Platform Platform dedicated to development and transfer of 3D printing technologies for industrial and academic partners, including multi-material and multi-scale manufacturing capabilities.
  • Balard Analysis and Characterization Platform (PAC) High-tech equipment hub for physico-chemical analysis and characterization, from molecules to materials, open to industrial partners.
  • National Spark Plasma Sintering Platform (PNF2-CNRS) Platform at CIRIMAT in Toulouse for shaping materials using SPS (Spark Plasma Sintering) technology, open to public and private laboratories.
  • SynBio3 Peptide and Polymer Synthesis Platform Interface platform between chemistry and biology offering peptide and polymer synthesis services for academics and industrialists in medicine, biology, chemistry and pharmacology.
  • Corporate Training Programs (CNRS Formation Entreprises) Competency transfer and R&D training programs delivered with CNRS Formation Entreprises covering HPLC purification, mechanochemistry, sol-gel coatings, oligonucleotide synthesis, electrochemical characterization, peptide synthesis and nanoparticle systems.

Quantifiable outcome

  • €31.8 million in partnership research funding
  • +8 more outcomes

Companies that use Carnot Chimie Balard CIRIMAT

Customer profile

Named customers12 records

Segments10 records

Ideal customer profiles1 record

Carnot Chimie Balard CIRIMAT technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature11 records

Carnot Chimie Balard CIRIMAT partnerships and signals

Strategic signal

Partnerships

23 partnerships are on record, tiered core, major and supporting.

  • Shire/TakedacoreStrategic or Co-development Partner · 1 January 2018Global biotech company entered collaboration agreement in March 2018 for application of NanoMedSyn AMFA technology in Pompe disease treatment. Shire/Takeda (Cambridge, MA) supporting development of lysosomal storage disorder therapies.
  • CNRS (Centre National de la Recherche Scientifique)coreStrategic or Co-development Partner · 1 January 2016Primary research partner providing institutional support and framework. The institute depends directly on CNRS as one of its 5 educational institution supervisors. CNRS researchers including Olivier Dautel, Claude Estournès, Emmanuel Flahaut, Laure Monconduit lead key research programs.
  • Thales Alenia SpacecoreStrategic or Co-development Partner · 1 January 2011Space technology company partnered with CIRIMAT to develop Ecorel™ Oxal AG high thermal conductivity solder for embedded electronics in satellites. Contributed to patent deposit in 2011.
  • École Nationale Supérieure de Chimie de Montpellier (ENSCM)coreStrategic or Co-development Partner · 1 January 2006Host institution for ICGM and IBMM research units. Provides ChemLab industrial pilot plant facility for company partnerships. Located at 240 av. du Pr. E. Jeanbrau, Montpellier.
  • Institut National Polytechnique de Toulouse (INP Toulouse)coreStrategic or Co-development Partner · 1 January 2006Host institution for CIRIMAT research unit in Toulouse. Supports the National Spark Plasma Sintering Platform (PNF2-CNRS).
  • Université de ToulousecoreStrategic or Co-development Partner · 1 January 2006University partner hosting CIRIMAT laboratory at 118 route de Narbonne, Toulouse. University Toulouse III-Paul Sabatier researchers contributed to Mobilint and Ecorel patents.
  • Université de MontpelliercoreStrategic or Co-development Partner · 1 January 2006University partner hosting ICGM and IBMM research units. Supports SATT AxLR technology transfer. Home to IBMM's Artificial Biopolymers Department where Womed is headquartered.
  • InventecmajorStrategic or Co-development PartnerCompany commercializing Ecorel™ Oxal AG high thermal conductivity solder pastes developed from CIRIMAT-Thales research. Licensed the technology for aerospace, power electronics, and optoelectronics applications. Presented at SMT trade show 2018.
  • AthéormajorStrategic or Co-development PartnerStartup founded 2009 by Jean-Denis Borras and Dr. Olivier Dautel exploiting Glass'in® technology from ICGM. Multiple research collaboration contracts since 2008, with 4 contracts including CNRS-funded R&D engineer placement.
  • SÿniamajorStrategic or Co-development PartnerSME with 18 employees specializing in high-end digital printing, European leader in doming since 2005. CIFRE thesis collaboration with ICGM resulted in bio-sourced polyurethane resin and 2 international patents. Awarded Carnot 2023 prize.
  • NanoMedSynmajorStrategic or Co-development PartnerBiotech PME founded 2012 developing targeted therapies based on mannose 6-phosphate receptor pathway. Spin-off from IRCM, IBMM, ICGM. Received EMA orphan drug designation. Collaborates with Shire/Takeda on Pompe disease treatment.
  • WomedmajorStrategic or Co-development PartnerMedtech startup founded February 2018 developing Womed Leaf biodegradable intrauterine barrier. Spin-off from IBMM Artificial Biopolymers and CHU Nîmes. Won Grand Prix iLab 2018. Founded by Gonzague Issenmann, Xavier Garric, Stéphanie Huberlant.
  • NorimatmajorStrategic or Co-development PartnerSpin-off from CIRIMAT founded 2016 by Romain Epherre, Yannick Beynet, and Claude Estournès. Licensed Mobilint patent from SATT TTT for flash sintering applications in aeronautics.
  • BiomanitymajorStrategic or Co-development PartnerFrench biotech startup developing 100% biodegradable, bio-sourced superabsorbent polymer from chitosan platform molecule. Pr. Ghislain David joined as CTO after research collaboration. Applications in cosmetics, hygiene, agriculture.
  • Institut de Recherche en Cancérologie de Montpellier (IRCM)coreStrategic or Co-development PartnerAcademic research institute collaborating on NanoMedSyn targeted therapy development as part of translational approach involving IRCM, IBMM, and ICGM.
  • Lafarge HolcimmajorStrategic or Co-development PartnerIndustrial participant in CO2 capture and valorization day (March 2025) with presentation by Thomas De Charette on decarbonation strategies.
  • AxensmajorStrategic or Co-development PartnerIndustrial partner participating in CO2 capture and valorization industry day showcasing institute capabilities in carbon utilization research.
  • Jagiellonian University (Poland)majorStrategic or Co-development PartnerAcademic collaboration with IBMM's Green Chemistry team on continuous flow metathesis research published in Green Chemistry journal (2017).
  • SATT AxLRcoreImplementation/ SI/ Consulting PartnerTechnology Transfer Acceleration Company supporting invention disclosure, patent filing, and startup creation for Womed and other institute spin-offs.
  • SATT Toulouse Tech Transfer (TTT)coreImplementation/ SI/ Consulting PartnerTechnology transfer partner signing Mobilint license agreement with Norimat in November 2017 for CIRIMAT patent commercialization.
  • LAAS-CNRScoreStrategic or Co-development PartnerResearch partner co-leading MultiFab platform for multi-material additive manufacturing with CIRIMAT. Funded by FEDER and Occitanie Region.
  • Vaincre les Maladies Lysosomales (VML)supportingOthersPatient organization supporting NanoMedSyn research on lysosomal storage disorders, including VML-Swiss collaboration.
  • Association Française contre les Myopathies (AFM-Téléthon)supportingOthersFrench muscular dystrophy association supporting NanoMedSyn research on lysosomal storage disorders through patient advocacy and funding.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Carnot Chimie Balard CIRIMAT competitors and assessment

Company assessment

Direct peers

  • SINTEF: Norway's largest contract research organization with materials, chemistry, and applied process engineering programs for Nordic and European industries. Compares directly to CBC's mix of industry-partnership research, technology platform access, and spin-off generation.
  • CSIC (Consejo Superior de Investigaciones Científicas): Spain's largest public research institution, operating across chemistry, materials, and life sciences with industrial partnership programs. Comparable in scale, thematic breadth, and the public-institute contract-research model applied to European industry.
  • TNO (Netherlands Organisation for Applied Scientific Research): Dutch public applied-research organization with industry-partnership programs in energy, materials, and circular chemistry. Like CBC, TNO operates national technology platforms and licenses spin-outs, making it a directly comparable European public R&D partnership model.
  • CEA (Commissariat à l'énergie atomique et aux énergies alternatives): France's largest public research organization with deep capabilities in energy, materials, and chemistry. Operates multiple technology platforms and partnership research programs with industry — a close structural analog to Carnot Chimie Balard CIRIMAT's Carnot institute model, and a frequent co-applicant on French national R&D programs.
  • Manufacturing Technology Centre (MTC): UK Catapult center focused on advanced manufacturing and additive manufacturing R&D with industrial partners. Shares the model of operating dedicated technology platforms (analogous to CBC's MultiFab and PNF2 platforms) funded by a mix of public grants and industry contracts.
  • Fraunhofer Society: Germany's applied research network with 76 institutes conducting contract research for industry across materials, chemistry, surface engineering, and manufacturing. The Fraunhofer model is the most-cited international comparator for the French Carnot institute structure, including revenue mix (public base + industry contracts) and IP/spin-off generation.
  • Institut de Recherche Paul Pascal (CNRS UMR 5031): CNRS-hosted chemistry and materials research unit in Bordeaux with strong industry-partnership heritage in polymers, soft matter, and nanochemistry. Directly comparable as a French public chemistry/materials unit conducting contract research with industrial partners and producing spin-offs.
  • Carnot M.I.N.E.S Institute: Another French Carnot institute focused on materials, microelectronics, and industrial processes. Shares the Carnot label, public funding model, and industry-partnership structure with CBC, with significant overlap in materials engineering and additive manufacturing R&D.

Broad incumbents

  • National Physical Laboratory (NPL): UK's national measurement institute with extensive capabilities in materials characterization, analytical chemistry, and standards — directly analogous to CBC's Balard Analysis and Characterization Platform (PAC). Serves industrial clients with metrology and contract research services.
  • CEA-Leti: CEA's micro/nanotechnology R&D laboratory serving semiconductor and advanced materials industries. While its thematic focus (microelectronics, MEMS) differs from CBC's chemistry/materials breadth, its public-private partnership model and platform-licensing approach are highly comparable.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Carnot Chimie Balard CIRIMAT social profiles

Digital presence

Carnot Chimie Balard CIRIMAT financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Carnot Chimie Balard CIRIMAT leadership team

Management profile

Number of profiles

Carnot Chimie Balard CIRIMAT funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Carnot Chimie Balard CIRIMAT M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carnot Chimie Balard CIRIMAT

What does Carnot Chimie Balard CIRIMAT do?

The institute provides contract-based partnership research in Chemistry, Materials and Processes across five thematic areas (Energy, Green Chemistry and Processes, Health and Cosmetics, Materials for Transport, High Performance Materials), backed by six shared technology platforms for synthesis, characterization, additive manufacturing, spark plasma sintering, and scale-up. It also licenses proprietary technologies such as Glass'in® and Ecorel™ Oxal AG, supports spin-off creation, and delivers competency-transfer training programs for industrial partners.

Is Carnot Chimie Balard CIRIMAT a public or private company?

Carnot Chimie Balard CIRIMAT is a private company. It is classified as state government owned and is currently operating.

When was Carnot Chimie Balard CIRIMAT founded?

Carnot Chimie Balard CIRIMAT was founded in 2006. It employs 11 to 50 people.

Where is Carnot Chimie Balard CIRIMAT based?

Carnot Chimie Balard CIRIMAT is headquartered in Montpellier, France, in the Europe region.

How does Carnot Chimie Balard CIRIMAT make money?

Three revenue lines are on record. Partnership Research Contracts are the primary driver. The others are technology Platform Services and training Programs.

Who are Carnot Chimie Balard CIRIMAT's main competitors?

Direct peers on record are SINTEF, CSIC (Consejo Superior de Investigaciones Científicas), TNO (Netherlands Organisation for Applied Scientific Research), CEA (Commissariat à l'énergie atomique et aux énergies alternatives), Manufacturing Technology Centre (MTC), Fraunhofer Society, Institut de Recherche Paul Pascal (CNRS UMR 5031) and Carnot M.I.N.E.S Institute. Broad incumbents are National Physical Laboratory (NPL) and CEA-Leti.

Does Carnot Chimie Balard CIRIMAT have an API?

No public API is recorded for Carnot Chimie Balard CIRIMAT.

What industry is Carnot Chimie Balard CIRIMAT in?

Carnot Chimie Balard CIRIMAT's product category is Industrial Contract R&D and Technology Platforms (Chemistry, Materials and Processes). Its primary akta.pro industry code is BPAIAAAK, Science, Technology & Innovation Administration (National R&D Policy), with a secondary code of IMAAAJAA, Additive Manufacturing Research & Innovation Labs. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales